ClinicalTrials.Veeva

Menu

Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With Hypertension

S

Solvay

Status and phase

Completed
Phase 2

Conditions

Hypertension

Treatments

Drug: Daglutril

Study type

Interventional

Funder types

Industry

Identifiers

NCT00160212
S306.2.008
2004-000305-21

Details and patient eligibility

About

This study is to compare the efficacy and safety of increasing doses of SLV306 with amlodipine.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • sitting office diastolic blood pressure between 90 and 109 mmHg
  • office systolic blood pressure between 140 and 179 mmHg
  • mean day-time diastolic 24-h ABPM blood pressure >= 85 mmHg inclusive at baseline

Exclusion criteria

  • known secondary hypertension
  • decompensated congestive heart failure

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

Trial contacts and locations

130

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems